<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE90CA04-1D62-4D88-B6C3-6C30EC90B31E"><gtr:id>AE90CA04-1D62-4D88-B6C3-6C30EC90B31E</gtr:id><gtr:name>VU University Medical Center</gtr:name><gtr:address><gtr:line1>VU University Medical Center</gtr:line1><gtr:line2>vd Boechorststraat 7</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E4FC0BA5-AA47-4EA7-9A0F-BEB082F633B8"><gtr:id>E4FC0BA5-AA47-4EA7-9A0F-BEB082F633B8</gtr:id><gtr:firstName>Kit-Yi</gtr:firstName><gtr:surname>Leung</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/534E81AC-9DCD-4969-9740-980D137F6062"><gtr:id>534E81AC-9DCD-4969-9740-980D137F6062</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Copp</gtr:surname><gtr:orcidId>0000-0002-2544-9117</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BAA12657-4EC0-44F2-8692-7F31391D0C43"><gtr:id>BAA12657-4EC0-44F2-8692-7F31391D0C43</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Greene</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601546"><gtr:id>08C1AD6E-963C-45BC-A1FF-2CE4CFF9DB90</gtr:id><gtr:title>Inositol-preventable neural tube defects: understanding the molecular causes and mechanisms of prevention</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601546</gtr:grantReference><gtr:abstractText>During early pregnancy, a crucial event in the developing embryo is the formation of the neural tube , which will later develop into the brain and spinal cord. Failure of the neural tube to form correctly leads to a group of birth defects called neural tube defects (NTDs), in which the brain and/or spinal cord of the fetus become irreversibly damaged, resulting in death before or shortly after birth, or handicap in surviving babies. Overall, NTDs occur in around 1 per 1,000 pregnancies although the rate varies and is significantly higher in some regions (e.g. Northern Ireland and Scotland). Worldwide, approximately 130,000 cases occur every year. The risk of NTDs depends on both inherited genetic factors and non-genetic factors such as diet, but the exact causes are not well understood. However, the risk of an affected pregnancy can be substantially reduced if the mother takes folic acid supplements before and during early pregnancy. Unfortunately, not all cases of NTDs are preventable by folic acid and for this reason, we are seeking additional protective approaches. Using a mouse model that naturally develops folate-resistant NTDs we found that another vitamin, inositol, can prevent NTDs, and we are now carrying out a clinical trial to test whether inositol prevents NTDs in humans. There are two main aims of the present research proposal. First, we will investigate the cause of the inositol-preventable NTDs in the mouse. We have used a technique that lets us separate many proteins and compare which ones are present in normal embryos and those that develop NTDs. We have detected several proteins that seem to be present at lower abundance or in abnormally modified forms in embryos developing NTDs. We will build on these studies by analysing the proteins that seem to be abnormal in the embryos that develop spina bifida. Understanding the role of specific proteins in the mouse may indicate risk factor genes in humans. The second aim of the research is to work out exactly how inositol prevents NTDs, as this may allow improvements to be made in the therapeutic approach. Knowledge of the causes of NTDs in humans may then allow more accurate counselling for affected families who are considering a further pregnancy, and may allow identification of women who will benefit from inositol supplementation.</gtr:abstractText><gtr:technicalSummary>Neural tube defects (NTDs), such as spina bifida and anencephaly, are severe congenital malformations caused by failure of closure of the embryonic neural tube. Folic acid supplementation can prevent many cases of NTDs but a significant proportion (at least 30%) are unresponsive, and these defects remain a major health issue in the UK and worldwide. As a system to investigate the mechanisms underlying development of ?folate-resistant? NTDs, and to evaluate potential therapies, the curly tail mutant mouse provides a well-studied model. The incidence of defects in curly tail is influenced by both multiple genetic and environmental factors, as in humans.
 We found previously that NTDs in curly tail can be prevented by inositol, acting through a protein kinase C (PKC)-dependent mechanism. This finding suggests that inositol may represent a possible adjunct therapy to folic acid for prevention of NTDs. Indeed, we recently initiated a clinical trial to test this possibility. Our present goals are: (1) to understand the molecular basis of NTDs in the curly tail mouse and (2) to further define the mechanism by which NTDs can be prevented by inositol. In a recent proteomic screen, we compared curly tail and genetically matched wild type embryos, using 2D protein gels and mass spectrometry. We identified a number of protein differences involving changes in protein abundance and post-translational protein modification. Our working hypothesis is that these changes may be associated with predisposition to NTDs.
 Here, we will characterise the specific changes in individual candidate proteins by detailed examination of the abundance and spectrum of post-translational variants. We will then evaluate the potential role of the most promising candidate proteins in neural tube closure. Correction of mutant protein profiles by inositol treatment will support such a role, particularly if this is dependent on the PKC isoforms we previously found to be necessary for prevention of NTDs. Tissue expression and subcellular localization will be examined as these may indicate disruption of protein function. Since the curly tail mutation is thought to represent a hypomorphic allele of the transcription factor, Grhl3, we will also examine the protein profile of Grhl3 null mutants, which also exhibit NTDs, in parallel with curly tail. These studies will allow us to prioritise candidate proteins for functional analysis to directly test their requirement in neural tube closure and/or the prevention of NTDs by inositol.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>603799</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Karolinska - Genetics of NTDs</gtr:description><gtr:id>32A11937-F722-4562-B4BA-36F356E7DB59</gtr:id><gtr:impact>We showed that reduced expression of grainyhead-like3 is the cause of neural tube defects in the curly tail mouse model. We identified a polymorphism as a modifier of neural tube defects risk in curly tail mice and began analysis in human patients. Publications: 18683893 and 17720888</gtr:impact><gtr:outcomeId>C680BD3EA59-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator has contributed to design and analysis of microarray and transgenic investigations of grainyhead-like mutant mice. In addition Dr Gustavsson has collected patient DNA samples for analysis of candidate genes for neural tube defects.</gtr:partnerContribution><gtr:piContribution>We have been investigating the development and prevention of neural tube defects in grainyhead-like3 mutant mice. These studies have involved generation of novel transgenic mouse strains. Proteomic analysis has identified a modifier gene, which is a candidate to be involved in human neural tube defects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Folate assays</gtr:description><gtr:id>8C3F29F7-720B-4F56-A9B4-CCC0F860E6D3</gtr:id><gtr:impact>This collaboration enabled measurement of folate in embryos that developed under differing conditions, to correlate folate status with neural tube defect risk. Publications: 18753144 and 19824061</gtr:impact><gtr:outcomeId>05684E6D1B5-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator contributed reagents and expertise to enable us to establish microbiological folate assays, and contributed expertise in data analysis.</gtr:partnerContribution><gtr:piContribution>We found that folate deficiency increases suceptibility to neural tube defects in various mouse strains that are genetically predisposed to neural tube defects. In addition, we showed that in some cases these defects were preventable by inositol. We performed biochemical analysis of folate content in different genetic models under varying dietary conditions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Engineering, Division of Fluid Mechanics</gtr:department><gtr:description>Inositol assay</gtr:description><gtr:id>58B49811-FD86-4127-9EB4-C4E776A3A539</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>58b6e7ec0371a0.68660821-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator has developed novel methodology for high throughput analysis of inositol. Together we are testing the method and applying to biological samples.</gtr:partnerContribution><gtr:piContribution>Our research group has developed methodology for analysis of inositol in biological samples. We have also analysed the effect of inositol supplementation in animal models. This work has led to a clinical trial of inositol for prevention of neural tube defects. These projects require analysis of inositol in large sets of samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>VU University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>DNA methylation &amp;amp; folate/inositol deficiency</gtr:description><gtr:id>E82AE3D3-72D2-4233-B68A-9CF79A8816F1</gtr:id><gtr:impact>We observed reduced methylation in embryos treated with methylation cycle inhibitors, but not in folate-deficient embryos (Publication 18753144).</gtr:impact><gtr:outcomeId>EB5A5D75ACC-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator has performed mass spectrometry based analysis of DNA methylation on embryo samples from mutant mouse strains maintained under dietary conditions that predispose to neural tube defects.</gtr:partnerContribution><gtr:piContribution>We found that folate and/or inositol deificient dets increase the frequency of neural tube defects in mutant mouse strains. Folate deficiency may impact the methylation cycle, which we previously found to be required for neural tube formation. This raised the possibility that DNA methylation may be altered - the area of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Lamin B1 Cell Biology</gtr:description><gtr:id>742A34E3-8EF5-4D5C-B1A8-4572C27A6AC1</gtr:id><gtr:impact>This data forms part of a manuscript to be submitted late 2010.</gtr:impact><gtr:outcomeId>ryxxedQmv4G-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators carried out FLIP assay and cell morphometric analysis to test the functional effect of a variant of lamin B1 that we found to affect susceptibility to spina bifida</gtr:partnerContribution><gtr:piContribution>We identified a variant form of lamin B1 in mice that are predisposed to spina bifida. We carried otu genetic experiments that showed that the lamin B1 variant strongly influences risk of spina bifida. We generated constructs and primary cell lines for analysis by our collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Congenital Anomaly Register meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>29A83D61-98C8-4C5B-8686-BB698B31B563</gtr:id><gtr:impact>Scientific contact and invited speaker for the Congenital Anomaly Register &amp;amp; Information Service, Wales.

Increased awareness of inositol as possible preventive agent for neural tube defects and the PONTI clinical trial.</gtr:impact><gtr:outcomeId>0D9F3FA7102</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anomalies of the Fetal CNS, Neural Tube Defects and the PONTI Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F86B1166-73FB-4F45-9BDD-A84FA531FC1C</gtr:id><gtr:impact>Two presentations of 15 minutes duration entitled 'Developmental Biology of the CNS' and 'Prevention of Human NTDs'. The audience comprised healthcare professionals in the field of obstetrics and fetal medicine. Enthusiastic feedback resulted in greater participation in current clinical trial.

Improved participation in clinical trial.</gtr:impact><gtr:outcomeId>AF562FF9717</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio - Five Live</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>41741565-40F2-4AB4-BBCE-3C8C466E76F6</gtr:id><gtr:impact>Live radio interview discussing spina bifida, the need for women to take folic acid and the possibility that additional therapies are required. Resulted in increased awareness of clinical trial for prevention of neural tube defects by inositol - additional women entered trial after hearing radio interview.

Additional media interest in clinical trial. Contact from potantial trial participants and clnicians</gtr:impact><gtr:outcomeId>BibxJSSDgfg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News 24, BBC Online, BBC Regional News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D4734EAF-C5BC-47B2-B04B-3D7E5BC3CB98</gtr:id><gtr:impact>I was interviewed for a television piece which focussed on spina bifida, its possible prevention by folic acid and the need for additional therapies as folic acid does not prevent all cases. The interview also introduced our current clinical trial.

Increased recruitment into clinical trial.</gtr:impact><gtr:outcomeId>QG2ydyyDhUV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PONTI Study Outcomes reported</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>16C31CA3-190A-4753-AB32-8B386AF9D622</gtr:id><gtr:impact>Publicity surrounding publication of findings from the PONTI study for prevention of neural tube defects. Media outlets included London Evening Standard and BBC online as well as newsletter of Shine.</gtr:impact><gtr:outcomeId>58b6ef9dca13f4.65049815</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://www.ucl.ac.uk/ich/research/developmental-biology-cancer/developmental-biology-birth-defects/copp-greene-research-group/ponti_study</gtr:url><gtr:year>2014,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC TV - Breakfast</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83D0314B-CB75-468B-BEFF-E6C331487B6C</gtr:id><gtr:impact>Live TV interview discussing spina bifida, the need for women to take folic acid and the possibility that additional therapies are required. Resulted in increased awareness of clinical trial for prevention of neural tube defects by inositol - additional women entered trial after seeing TV interview.

Increased public awareness of neural tube defects, the need for folic acid supplementation and the possible benefit of additional therapies, such the as one being tested in the clinical trial run by this resaerch group.</gtr:impact><gtr:outcomeId>KF65TStG9LL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Otto Wolff Lecture.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B145C424-7298-4378-97E4-7829E08CB0A6</gtr:id><gtr:impact>Presentation of a 1 hour lecture entitled 'Inositol a novel preventive therapy for neural tube defects alongside folic acid?'. This is an invited lecture to the combined academic and medical staff of UCL Institute of Child Health and Great Ormond Street Hospital NHS Trust.

Improved knowledge of inositol as a possible therapy for NTDs</gtr:impact><gtr:outcomeId>0804D9A808C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper/online coverage (Inositol Study)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5B64067C-CEFC-4AEC-9E03-6135CB8E8F0C</gtr:id><gtr:impact>Press release and media interviews resulted in coverage on the BBC online website and in newspapers (eg. Evening Standard) which sparked online discussion ( 3 international news outlets) and further dissemination of findings (eg. via social media).</gtr:impact><gtr:outcomeId>56caf53ecd3c40.39408106</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/uk-scotland-35503529</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sparks Project Grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Sparks</gtr:fundingOrg><gtr:id>058A7FD2-0695-484D-B4FF-6FA4D0AE8D5A</gtr:id><gtr:outcomeId>Ln4P7guDYaK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1366000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme grant</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F726AC10-3F93-4CEB-9259-9305843523CB</gtr:id><gtr:outcomeId>E14B6A72E3D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A mouse line was generated that carries a BAC containing the Grhl3 gene. This results in over-expression of Grhl3 in the embryo.</gtr:description><gtr:id>EE9CDDB0-A7B0-4AAA-947C-0FEE2715C093</gtr:id><gtr:impact>The mice were used in a 'transgenic rescue' experiment which showed that neural tube defects in curly tail mice result from reduced expression of Grhl3.</gtr:impact><gtr:outcomeId>PKqNiKeJ863</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Grainyhead-like 3 transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9C2A01FC-591E-4549-BCA6-B772182B0479</gtr:id><gtr:title>Inositol, neural tube closure and the prevention of neural tube defects.</gtr:title><gtr:parentPublicationTitle>Birth defects research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>585d3173a0d8c9.85231237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B171ED-B4CC-4F65-9295-29AC247C0B55</gtr:id><gtr:title>Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84b0afb3708c72086570db9854438ed7"><gtr:id>84b0afb3708c72086570db9854438ed7</gtr:id><gtr:otherNames>Leung KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>jdVrPFejoPM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3944EDB4-B9CE-4F34-B505-F2C28EAE50FA</gtr:id><gtr:title>Genetics of human neural tube defects.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>F81D544E06F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24CA9AFD-10A0-43C6-9B77-BB604EAAEC4D</gtr:id><gtr:title>Neural tube defects induced by folate deficiency in mutant curly tail (Grhl3) embryos are associated with alteration in folate one-carbon metabolism but are unlikely to result from diminished methylation.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d26ee11f574ee83f0b765efd4a21c283"><gtr:id>d26ee11f574ee83f0b765efd4a21c283</gtr:id><gtr:otherNames>De Castro SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>pm_12616_26_20589880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>269BA02F-51A0-4096-9136-A52326C57ECC</gtr:id><gtr:title>The genetic background of the curly tail strain confers susceptibility to folate-deficiency-induced exencephaly.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3786b3eb827e7974c346cd8ec94580b"><gtr:id>d3786b3eb827e7974c346cd8ec94580b</gtr:id><gtr:otherNames>Burren KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>0B9F0887F25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F3DD672-C451-4FA7-A9B7-54DFC7C5E2A3</gtr:id><gtr:title>Grainyhead genes and mammalian neural tube closure.</gtr:title><gtr:parentPublicationTitle>Birth defects research. Part A, Clinical and molecular teratology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15cddcaf88dfda2bbaac93a637b9996e"><gtr:id>15cddcaf88dfda2bbaac93a637b9996e</gtr:id><gtr:otherNames>Gustavsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1542-0752</gtr:issn><gtr:outcomeId>503A5F16BF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FBD8F16-AD28-443D-B464-68193561577F</gtr:id><gtr:title>Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15cddcaf88dfda2bbaac93a637b9996e"><gtr:id>15cddcaf88dfda2bbaac93a637b9996e</gtr:id><gtr:otherNames>Gustavsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>66BB470C732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC65A7BE-3804-427C-BE11-655F6B73F998</gtr:id><gtr:title>Inositol for the prevention of neural tube defects: a pilot randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>56cada2f7c93d6.15658612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0A91461-7400-4F6C-9C10-B9B3E36BC028</gtr:id><gtr:title>Magnetic resonance virtual histology for embryos: 3D atlases for automated high-throughput phenotyping.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d550230afd38a5f9be54da2af5d1140"><gtr:id>6d550230afd38a5f9be54da2af5d1140</gtr:id><gtr:otherNames>Cleary JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>DhbPmoXJWZD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61A81685-B4D3-47F3-BB1F-F063F53A5042</gtr:id><gtr:title>Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3786b3eb827e7974c346cd8ec94580b"><gtr:id>d3786b3eb827e7974c346cd8ec94580b</gtr:id><gtr:otherNames>Burren KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>E219C781E40</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C74A4A7F-CAD6-46DC-8F22-7A42CC0C9082</gtr:id><gtr:title>Post-translational regulation of Crmp in developing and regenerating chick spinal cord.</gtr:title><gtr:parentPublicationTitle>Developmental neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f3265ec4bcff46ab210439351b641a"><gtr:id>15f3265ec4bcff46ab210439351b641a</gtr:id><gtr:otherNames>G?gel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-8451</gtr:issn><gtr:outcomeId>gefFXy4hHdc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABFDAFF5-E40E-4D27-8214-B224DF7F4064</gtr:id><gtr:title>Development of the vertebrate central nervous system: formation of the neural tube.</gtr:title><gtr:parentPublicationTitle>Prenatal diagnosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d5ad6709a1d670da68174acc885ac4"><gtr:id>05d5ad6709a1d670da68174acc885ac4</gtr:id><gtr:otherNames>Greene ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-3851</gtr:issn><gtr:outcomeId>C1C3085938E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601546</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>